Loading…

Loading grant details…

Completed PHD TRAINING FELLOWSHIP FOR CLINICIANS Europe PMC

Defining the pathophysiological mechanisms underlying Low VWF in the Low VWF in Ireland Cohort (LoVIC) study


Funder Wellcome Trust
Recipient Organization Royal College of Surgeons in Ireland
Country United Kingdom
Start Date Jan 11, 2021
End Date Jan 10, 2024
Duration 1,094 days
Number of Grantees 1
Roles Award Holder
Data Source Europe PMC
Grant ID 222934
Grant Description

Von Willebrand Factor (VWF) is a protein that blood needs to clot normally. VWF is made by cells that line our blood vessels called endothelial cells. About 1 in 100 people inherit low levels of Von Willebrand Factor. This means that they have a lifelong bleeding disorder known as Von Willebrand Disease (VWD).

People with this disease bruise easily and suffer from nosebleeds. They also sometimes bleed after surgery or after having a tooth removed. We do not fully understand why these patients have low levels of VWF. This is especially true for patients whose levels are only slightly less than usual. This group of patients is known as ‘Low VWF’.

People with ‘Low VWF’ also often have bleeding that is more than would be expected. To better understand this disorder, we will study why these patients have low VWF levels. We will study if they are making less VWF or clearing VWF from their circulation too quickly. Finally, we will study why these patients bleed by looking at other parts of the clotting system.

This will help improve how we diagnose and treat these patients.

All Grantees

Royal College of Surgeons in Ireland

Advertisement
Discover thousands of grant opportunities
Advertisement
Browse Grants on GrantFunds
Interested in applying for this grant?

Complete our application form to express your interest and we'll guide you through the process.

Apply for This Grant